{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:19:11Z","timestamp":1788668351427,"version":"build-2803163510"},"reference-count":109,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>In recent years, novel findings have progressively and promisingly supported the potential role of Artificial intelligence (AI) in transforming the management of various neoplasms, including hepatocellular carcinoma (HCC). HCC represents the most common primary liver cancer. Alarmingly, the HCC incidence is dramatically increasing worldwide due to the simultaneous \u201cpandemic\u201d spreading of metabolic dysfunction-associated steatotic liver disease (MASLD). MASLD currently constitutes the leading cause of chronic hepatic damage (steatosis and steatohepatitis), fibrosis, and liver cirrhosis, configuring a scenario where an HCC onset has been reported even in the early disease stage. On the other hand, HCC represents a serious plague, significantly burdening the outcomes of chronic hepatitis B (HBV) and hepatitis C (HCV) virus-infected patients. Despite the recent progress in the management of this cancer, the overall prognosis for advanced-stage HCC patients continues to be poor, suggesting the absolute need to develop personalized healthcare strategies further. In this \u201ccold war\u201d, machine learning techniques and neural networks are emerging as weapons, able to identify the patterns and biomarkers that would have normally escaped human observation. Using advanced algorithms, AI can analyze large volumes of clinical data and medical images (including routinely obtained ultrasound data) with an elevated accuracy, facilitating early diagnosis, improving the performance of predictive models, and supporting the multidisciplinary (oncologist, gastroenterologist, surgeon, radiologist) team in opting for the best \u201ctailored\u201d individual treatment. Additionally, AI can significantly contribute to enhancing the effectiveness of metabolomics\u2013radiomics-based models, promoting the identification of specific HCC-pathogenetic molecules as new targets for realizing novel therapeutic regimens. In the era of precision medicine, integrating AI into routine clinical practice appears as a promising frontier, opening new avenues for liver cancer research and treatment.<\/jats:p>","DOI":"10.3390\/diagnostics15030252","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T11:09:02Z","timestamp":1737544142000},"page":"252","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)?"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2970-9019","authenticated-orcid":false,"given":"Mario","family":"Romeo","sequence":"first","affiliation":[{"name":"Hepatogastroenterology Division, Department of Precision Medicine, University of Campania Luigi Vanvitelli, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4153-815X","authenticated-orcid":false,"given":"Marcello","family":"Dallio","sequence":"additional","affiliation":[{"name":"Hepatogastroenterology Division, Department of Precision Medicine, University of Campania Luigi Vanvitelli, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2392-3539","authenticated-orcid":false,"given":"Carmine","family":"Napolitano","sequence":"additional","affiliation":[{"name":"Hepatogastroenterology Division, Department of Precision Medicine, University of Campania Luigi Vanvitelli, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Basile","sequence":"additional","affiliation":[{"name":"Hepatogastroenterology Division, Department of Precision Medicine, University of Campania Luigi Vanvitelli, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0519-3049","authenticated-orcid":false,"given":"Fiammetta","family":"Di Nardo","sequence":"additional","affiliation":[{"name":"Hepatogastroenterology Division, Department of Precision Medicine, University of Campania Luigi Vanvitelli, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7600-290X","authenticated-orcid":false,"given":"Paolo","family":"Vaia","sequence":"additional","affiliation":[{"name":"Hepatogastroenterology Division, Department of Precision Medicine, University of Campania Luigi Vanvitelli, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2862-7619","authenticated-orcid":false,"given":"Patrizia","family":"Iodice","sequence":"additional","affiliation":[{"name":"Oncology Division, Monaldi Hospital, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0885-0793","authenticated-orcid":false,"given":"Alessandro","family":"Federico","sequence":"additional","affiliation":[{"name":"Hepatogastroenterology Division, Department of Precision Medicine, University of Campania Luigi Vanvitelli, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamasurg.2022.7989","article-title":"Management of Hepatocellular Carcinoma: A Review","volume":"158","author":"Brown","year":"2023","journal-title":"JAMA Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","article-title":"Epidemiology and Management of Hepatocellular Carcinoma","volume":"156","author":"Kulik","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/JHC.S61146","article-title":"Hepatocellular Carcinoma: A Review","volume":"3","author":"Balogh","year":"2016","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","article-title":"Global Epidemiology and Genetics of Hepatocellular Carcinoma","volume":"164","author":"Toh","year":"2023","journal-title":"Gastroenterology"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Dallio, M., Masarone, M., Romeo, M., Tuccillo, C., Morisco, F., Persico, M., Loguercio, C., and Federico, A. (2021). PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial. Front. Med., 8.","DOI":"10.3389\/fmed.2021.734847"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Romeo, M., Dallio, M., Scognamiglio, F., Ventriglia, L., Cipullo, M., Coppola, A., Tammaro, C., Scafuro, G., Iodice, P., and Federico, A. (2023). Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications. Cancers, 15.","DOI":"10.3390\/cancers15215178"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Dallio, M., Ventriglia, L., Romeo, M., Scognamiglio, F., Diano, N., Moggio, M., Cipullo, M., Coppola, A., Ziogas, A., and Netea, M.G. (2023). Environmental Bisphenol A Exposure Triggers Trained Immunity-Related Pathways in Monocytes. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1270391"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"101447","DOI":"10.1016\/j.jceh.2024.101447","article-title":"Epidemiology of Hepatocellular Carcinoma in India\u2014An Updated Review for 2024","volume":"14","author":"Giri","year":"2024","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/hepr.14047","article-title":"Etiological Changes of Liver Cirrhosis and Hepatocellular Carcinoma-Complicated Liver Cirrhosis in Japan: Updated Nationwide Survey from 2018 to 2021","volume":"54","author":"Enomoto","year":"2024","journal-title":"Hepatol. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s43046-020-0016-x","article-title":"Hepatocellular Carcinoma (HCC) in Egypt: A Comprehensive Overview","volume":"32","author":"Rashed","year":"2020","journal-title":"J. Egypt. Natl. Cancer Inst."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular Carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review","volume":"32","author":"Chan","year":"2023","journal-title":"J. Obes. Metab. Syndr."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Dallio, M., Romeo, M., Gravina, A.G., Masarone, M., Larussa, T., Abenavoli, L., Persico, M., Loguercio, C., and Federico, A. (2021). Nutrigenomics and Nutrigenetics in Metabolic-(Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives. Nutrients, 13.","DOI":"10.3390\/nu13051679"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41387-024-00294-2","article-title":"The Influence of Acute Lifestyle Changes on NAFLD Evolution in a Multicentre Cohort: A Matter of Body Composition","volume":"14","author":"Dallio","year":"2024","journal-title":"Nutr. Diabetes"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of Hepatocellular Carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"102406","DOI":"10.1016\/j.jceh.2024.102406","article-title":"Evolving Global Etiology of Hepatocellular Carcinoma (HCC): Insights and Trends for 2024","volume":"15","author":"Koshy","year":"2025","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A Multisociety Delphi Consensus Statement on New Fatty Liver Disease Nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"100485","DOI":"10.1016\/j.jlr.2023.100485","article-title":"From NAFLD to MASLD: Updated Naming and Diagnosis Criteria for Fatty Liver Disease","volume":"65","author":"Rinella","year":"2024","journal-title":"J. Lipid Res."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Kim, H., Lee, D.S., An, T.H., Park, H.-J., Kim, W.K., Bae, K.-H., and Oh, K.-J. (2021). Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094495"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Meroni, M., Longo, M., and Dongiovanni, P. (2024). Cardiometabolic Risk Factors in MASLD Patients with HCC: The Other Side of the Coin. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1411706"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Palma, R., Pronio, A., Romeo, M., Scognamiglio, F., Ventriglia, L., Ormando, V.M., Lamazza, A., Pontone, S., Federico, A., and Dallio, M. (2022). The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications. J. Clin. Med., 11.","DOI":"10.3390\/jcm11133649"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e35338","DOI":"10.1016\/j.heliyon.2024.e35338","article-title":"From MASLD to HCC: What\u2019s in the Middle?","volume":"10","author":"Provera","year":"2024","journal-title":"Heliyon"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Phoolchund, A.G.S., and Khakoo, S.I. (2024). MASLD and the Development of HCC: Pathogenesis and Therapeutic Challenges. Cancers, 16.","DOI":"10.3390\/cancers16020259"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Dallio, M., Sangineto, M., Romeo, M., Villani, R., Romano, A.D., Loguercio, C., Serviddio, G., and Federico, A. (2021). Immunity as Cornerstone of Non-Alcoholic Fatty Liver Disease: The Contribution of Oxidative Stress in the Disease Progression. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010436"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jhep.2021.08.012","article-title":"Epidemiology and Risk-Stratification of NAFLD-Associated HCC","volume":"75","author":"Ioannou","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC Strategy for Prognosis Prediction and Treatment Recommendation: The 2022 Update","volume":"76","author":"Reig","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ueg2.12286","article-title":"New Concepts in the Treatment of Hepatocellular Carcinoma","volume":"10","author":"Sidali","year":"2022","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.metabol.2017.01.011","article-title":"Artificial Intelligence in Medicine","volume":"69S","author":"Hamet","year":"2017","journal-title":"Metabolism"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/13645706.2019.1575882","article-title":"Introduction to Artificial Intelligence in Medicine","volume":"28","author":"Mintz","year":"2019","journal-title":"Minim. Invasive Ther. Allied Technol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Patel, S.K., George, B., and Rai, V. (2020). Artificial Intelligence to Decode Cancer Mechanism: Beyond Patient Stratification for Precision Oncology. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.01177"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1145\/2347736.2347755","article-title":"A Few Useful Things to Know About Machine Learning","volume":"55","author":"Domingos","year":"2012","journal-title":"Commun. ACM"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1016\/j.arth.2018.02.067","article-title":"Artificial Intelligence, Machine Learning, Deep Learning, and Cognitive Computing: What Do These Terms Mean and How Will They Impact Health Care?","volume":"33","author":"Bini","year":"2018","journal-title":"J. Arthroplast."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMp1606181","article-title":"Predicting the Future\u2014Big Data, Machine Learning, and Clinical Medicine","volume":"375","author":"Obermeyer","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nmeth.2967","article-title":"Bayesian Approach to Single-Cell Differential Expression Analysis","volume":"11","author":"Kharchenko","year":"2014","journal-title":"Nat. Methods"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/jmri.26852","article-title":"Machine Learning in Breast MRI","volume":"52","author":"Reig","year":"2020","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1148\/radiol.2021210391","article-title":"Machine Learning for Workflow Applications in Screening Mammography: Systematic Review and Meta-Analysis","volume":"302","author":"Hickman","year":"2022","journal-title":"Radiology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature14539","article-title":"Deep Learning","volume":"521","author":"LeCun","year":"2015","journal-title":"Nature"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13073-021-00968-x","article-title":"Deep Learning in Cancer Diagnosis, Prognosis and Treatment Selection","volume":"13","author":"Tran","year":"2021","journal-title":"Genome Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S2468-1253(24)00095-5","article-title":"Durvalumab or Placebo plus Gemcitabine and Cisplatin in Participants with Advanced Biliary Tract Cancer (TOPAZ-1): Updated Overall Survival from a Randomised Phase 3 Study","volume":"9","author":"Oh","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.gpb.2018.07.008","article-title":"Multi-Omics Analysis of Primary Cell Culture Models Reveals Genetic and Epigenetic Basis of Intratumoral Phenotypic Diversity","volume":"17","author":"Liu","year":"2019","journal-title":"Genom. Proteom. Bioinform."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Zeng, W.Z.D., Glicksberg, B.S., Li, Y., and Chen, B. (2019). Selecting Precise Reference Normal Tissue Samples for Cancer Research Using a Deep Learning Approach. BMC Med. Genom., 12.","DOI":"10.1186\/s12920-018-0463-6"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e192597","DOI":"10.1001\/jamanetworkopen.2019.2597","article-title":"Application of a Neural Network Whole Transcriptome-Based Pan-Cancer Method for Diagnosis of Primary and Metastatic Cancers","volume":"2","author":"Grewal","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Pan, Z., Namburi, S., Pattison, A., Posner, A., Balachander, S., Paisie, C.A., Reddi, H.V., Rueter, J., and Gill, A.J. (2020). CUP-AI-Dx: A Tool for Inferring Cancer Tissue of Origin and Molecular Subtype Using RNA Gene-Expression Data and Artificial Intelligence. EBioMedicine, 61.","DOI":"10.1016\/j.ebiom.2020.103030"},{"key":"ref_44","first-page":"1980","article-title":"Deep Learning Radio-Clinical Signatures for Predicting Neoadjuvant Chemotherapy Response and Prognosis from Pretreatment CT Images of Locally Advanced Gastric Cancer Patients","volume":"109","author":"Hu","year":"2023","journal-title":"Int. J. Surg."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejrad.2018.01.025","article-title":"Diagnosis and Staging of Hepatocellular Carcinoma (HCC): Current Guidelines","volume":"101","author":"Ayuso","year":"2018","journal-title":"Eur. J. Radiol."},{"key":"ref_46","unstructured":"European Association for the Study of the Liver (2018). EASL Clinical Practice Guidelines: Management of Hepatocellular Carcinoma. J. Hepatol., 69, 182\u2013236."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.31309","article-title":"Use of Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Systematic Review and Meta-Analysis","volume":"73","author":"Wolf","year":"2021","journal-title":"Hepatology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jhep.2023.02.022","article-title":"International Liver Cancer Association (ILCA) White Paper on Hepatocellular Carcinoma Risk Stratification and Surveillance","volume":"79","author":"Singal","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2147\/JHC.S308587","article-title":"Using the aMAP Risk Score to Predict Late Recurrence Following Radiofrequency Ablation for Hepatocellular Carcinoma in Chinese Population: A Multicenter Study","volume":"8","author":"Yang","year":"2021","journal-title":"J. Hepatocell Carcinoma"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3350\/cmh.2022.0402","article-title":"Clinical Practice Guidelines and Real-Life Practice in Hepatocellular Carcinoma: A Chinese Perspective","volume":"29","author":"Xie","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jhep.2020.07.025","article-title":"aMAP Risk Score Predicts Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis","volume":"73","author":"Fan","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jhep.2017.07.033","article-title":"Toronto HCC Risk Index: A Validated Scoring System to Predict 10-Year Risk of HCC in Patients with Cirrhosis","volume":"68","author":"Sharma","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-0037-1607452","article-title":"HCC Risk Scores: Useful or Not?","volume":"37","author":"Sherman","year":"2017","journal-title":"Semin. Liver Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jhep.2017.09.016","article-title":"Risk Factors and Prevention of Hepatocellular Carcinoma in the Era of Precision Medicine","volume":"68","author":"Fujiwara","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.gastha.2024.01.007","article-title":"A Machine Learning Model to Predict Risk for Hepatocellular Carcinoma in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease","volume":"3","author":"Sarkar","year":"2024","journal-title":"Gastro Hep Adv."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e2015626","DOI":"10.1001\/jamanetworkopen.2020.15626","article-title":"Assessment of a Deep Learning Model to Predict Hepatocellular Carcinoma in Patients with Hepatitis C Cirrhosis","volume":"3","author":"Ioannou","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/liv.14666","article-title":"GES: A Validated Simple Score to Predict the Risk of HCC in Patients with HCV-GT4-Associated Advanced Liver Fibrosis after Oral Antivirals","volume":"40","author":"Shiha","year":"2020","journal-title":"Liver Int."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/apt.18291","article-title":"Individualized HCC Surveillance Using Risk Stratification Scores in Advanced Fibrosis and Cirrhotic HCV Patients Who Achieved SVR: Prospective Study","volume":"61","author":"Shiha","year":"2025","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jhep.2023.05.042","article-title":"Machine Learning for Individualized Prediction of Hepatocellular Carcinoma Development after the Eradication of Hepatitis C Virus with Antivirals","volume":"79","author":"Minami","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jhep.2021.09.025","article-title":"An Artificial Intelligence Model to Predict Hepatocellular Carcinoma Risk in Korean and Caucasian Patients with Chronic Hepatitis B","volume":"76","author":"Kim","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL Clinical Practice Guidelines on the Management of Hepatocellular Carcinoma","volume":"82","author":"Sangro","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/gastro\/goaa011","article-title":"Radiomics Based on Artificial Intelligence in Liver Diseases: Where We Are?","volume":"8","author":"Hu","year":"2020","journal-title":"Gastroenterol. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Yang, Q., Wei, J., Hao, X., Kong, D., Yu, X., Jiang, T., Xi, J., Cai, W., Luo, Y., and Jing, X. (2020). Improving B-Mode Ultrasound Diagnostic Performance for Focal Liver Lesions Using Deep Learning: A Multicentre Study. EBioMedicine, 56.","DOI":"10.1016\/j.ebiom.2020.102777"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Chaiteerakij, R., Ariyaskul, D., Kulkraisri, K., Apiparakoon, T., Sukcharoen, S., Chaichuen, O., Pensuwan, P., Tiyarattanachai, T., Rerknimitr, R., and Marukatat, S. (2024). Artificial Intelligence for Ultrasonographic Detection and Diagnosis of Hepatocellular Carcinoma and Cholangiocarcinoma. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-71657-z"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000501082","article-title":"B-Mode Ultrasonography versus Contrast-Enhanced Ultrasonography for Surveillance of Hepatocellular Carcinoma: A Prospective Multicenter Randomized Controlled Trial","volume":"8","author":"Kudo","year":"2019","journal-title":"Liver Cancer"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3233\/CH-170275","article-title":"A Two-Stage Multi-View Learning Framework Based Computer-Aided Diagnosis of Liver Tumors with Contrast Enhanced Ultrasound Images","volume":"69","author":"Guo","year":"2018","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00330-019-06347-w","article-title":"Radiomics Machine-Learning Signature for Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients with Indeterminate Liver Nodules","volume":"30","author":"Mokrane","year":"2020","journal-title":"Eur. Radiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"101219","DOI":"10.1016\/j.jhepr.2024.101219","article-title":"Application of a Deep Learning Algorithm for the Diagnosis of HCC","volume":"7","author":"Yu","year":"2025","journal-title":"JHEP Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1007\/s00330-019-06205-9","article-title":"Deep Learning for Liver Tumor Diagnosis Part I: Development of a Convolutional Neural Network Classifier for Multi-Phasic MRI","volume":"29","author":"Hamm","year":"2019","journal-title":"Eur. Radiol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Zhen, S.-H., Cheng, M., Tao, Y.-B., Wang, Y.-F., Juengpanich, S., Jiang, Z.-Y., Jiang, Y.-K., Yan, Y.-Y., Lu, W., and Lue, J.-M. (2020). Deep Learning for Accurate Diagnosis of Liver Tumor Based on Magnetic Resonance Imaging and Clinical Data. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00680"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/s43018-020-0085-8","article-title":"Pan-Cancer Computational Histopathology Reveals Mutations, Tumor Composition and Prognosis","volume":"1","author":"Fu","year":"2020","journal-title":"Nat. Cancer"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/s41591-019-0462-y","article-title":"Deep Learning Can Predict Microsatellite Instability Directly from Histology in Gastrointestinal Cancer","volume":"25","author":"Kather","year":"2019","journal-title":"Nat. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/s41591-019-0508-1","article-title":"Clinical-Grade Computational Pathology Using Weakly Supervised Deep Learning on Whole Slide Images","volume":"25","author":"Campanella","year":"2019","journal-title":"Nat. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1001\/jama.2017.14585","article-title":"Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women with Breast Cancer","volume":"318","author":"Veta","year":"2017","journal-title":"JAMA"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41586-021-03512-4","article-title":"AI-Based Pathology Predicts Origins for Cancers of Unknown Primary","volume":"594","author":"Lu","year":"2021","journal-title":"Nature"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Lin, H., Wei, C., Wang, G., Chen, H., Lin, L., Ni, M., Chen, J., and Zhuo, S. (2019). Automated Classification of Hepatocellular Carcinoma Differentiation Using Multiphoton Microscopy and Deep Learning. J. Biophotonics, 12.","DOI":"10.1002\/jbio.201800435"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41698-020-0120-3","article-title":"Classification and Mutation Prediction Based on Histopathology H&E Images in Liver Cancer Using Deep Learning","volume":"4","author":"Chen","year":"2020","journal-title":"NPJ Precis. Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1002\/ctm2.102","article-title":"Deep Learning-Based Classification and Mutation Prediction from Histopathological Images of Hepatocellular Carcinoma","volume":"10","author":"Liao","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41746-020-0232-8","article-title":"Impact of a Deep Learning Assistant on the Histopathologic Classification of Liver Cancer","volume":"3","author":"Kiani","year":"2020","journal-title":"NPJ Digit. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nbt.3129","article-title":"Integrated Genome and Transcriptome Sequencing of the Same Cell","volume":"33","author":"Dey","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nmeth.3370","article-title":"G&T-Seq: Parallel Sequencing of Single-Cell Genomes and Transcriptomes","volume":"12","author":"Macaulay","year":"2015","journal-title":"Nat. Methods"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.18632\/oncotarget.26918","article-title":"Detection of Fusion Transcripts in the Serum Samples of Patients with Hepatocellular Carcinoma","volume":"10","author":"Yu","year":"2019","journal-title":"Oncotarget"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.ajpath.2024.02.017","article-title":"Serum Fusion Transcripts to Assess the Risk of Hepatocellular Carcinoma and the Impact of Cancer Treatment through Machine Learning","volume":"194","author":"Yu","year":"2024","journal-title":"Am. J. Pathol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s12664-018-0915-0","article-title":"Staging Systems of Hepatocellular Carcinoma: A Review","volume":"37","author":"Tellapuri","year":"2018","journal-title":"Indian J. Gastroenterol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/j.gastro.2022.09.005","article-title":"Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma","volume":"164","author":"Haber","year":"2023","journal-title":"Gastroenterology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.jhep.2020.07.026","article-title":"Association of Inflammatory Biomarkers with Clinical Outcomes in Nivolumab-Treated Patients with Advanced Hepatocellular Carcinoma","volume":"73","author":"Sangro","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00330-019-06318-1","article-title":"Residual Convolutional Neural Network for Predicting Response of Transarterial Chemoembolization in Hepatocellular Carcinoma from CT Imaging","volume":"30","author":"Peng","year":"2020","journal-title":"Eur. Radiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S1470-2045(23)00468-0","article-title":"Artificial Intelligence-Based Pathology as a Biomarker of Sensitivity to Atezolizumab-Bevacizumab in Patients with Hepatocellular Carcinoma: A Multicentre Retrospective Study","volume":"24","author":"Zeng","year":"2023","journal-title":"Lancet Oncol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3748\/wjg.v29.i8.1243","article-title":"Predictors of Early and Late Hepatocellular Carcinoma Recurrence","volume":"29","author":"Nevola","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jhbp.1408","article-title":"Questionnaire Survey of Japanese Board-Certified Expert Hepatobiliary and Pancreatic Surgeons and Instructors on the Surgical Indications for Hepatocellular Carcinoma","volume":"31","author":"Akahoshi","year":"2024","journal-title":"J. Hepato-Biliary-Pancreat. Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ebiom.2019.10.057","article-title":"Machine-Learning Analysis of Contrast-Enhanced CT Radiomics Predicts Recurrence of Hepatocellular Carcinoma after Resection: A Multi-Institutional Study","volume":"50","author":"Ji","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Nam, J.Y., Lee, J.-H., Bae, J., Chang, Y., Cho, Y., Sinn, D.H., Kim, B.H., Kim, S.H., Yi, N.-J., and Lee, K.-W. (2020). Novel Model to Predict HCC Recurrence after Liver Transplantation Obtained Using Deep Learning: A Multicenter Study. Cancers, 12.","DOI":"10.3390\/cancers12102791"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1002\/hep.31207","article-title":"Predicting Survival After Hepatocellular Carcinoma Resection Using Deep Learning on Histological Slides","volume":"72","author":"Saillard","year":"2020","journal-title":"Hepatology"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Yamashita, R., Long, J., Saleem, A., Rubin, D.L., and Shen, J. (2021). Deep Learning Predicts Postsurgical Recurrence of Hepatocellular Carcinoma from Digital Histopathologic Images. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-81506-y"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1007\/s00261-014-0130-0","article-title":"TNM\/Okuda\/Barcelona\/UNOS\/CLIP International Multidisciplinary Classification of Hepatocellular Carcinoma: Concepts, Perspectives, and Radiologic Implications","volume":"39","author":"Faria","year":"2014","journal-title":"Abdom. Imaging"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41379-020-00671-z","article-title":"Prediction of Early Recurrence of Hepatocellular Carcinoma after Resection Using Digital Pathology Images Assessed by Machine Learning","volume":"34","author":"Saito","year":"2021","journal-title":"Mod. Pathol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s12072-022-10321-y","article-title":"Deep Learning for Prediction of Hepatocellular Carcinoma Recurrence after Resection or Liver Transplantation: A Discovery and Validation Study","volume":"16","author":"Liu","year":"2022","journal-title":"Hepatol. Int."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.jhep.2022.01.014","article-title":"Artificial Intelligence for the Prevention and Clinical Management of Hepatocellular Carcinoma","volume":"76","author":"Calderaro","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1109\/TIP.2022.3141258","article-title":"Progressive Transfer Learning","volume":"31","author":"Yu","year":"2022","journal-title":"IEEE Trans. Image Process."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41591-020-1034-x","article-title":"SPIRIT-AI and CONSORT-AI Consensus Group Guidelines for Clinical Trial Protocols for Interventions Involving Artificial Intelligence: The SPIRIT-AI Extension","volume":"26","author":"Liu","year":"2020","journal-title":"Nat. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/s41591-020-1034-x","article-title":"SPIRIT-AI and CONSORT-AI Working Group Reporting Guidelines for Clinical Trial Reports for Interventions Involving Artificial Intelligence: The CONSORT-AI Extension","volume":"26","author":"Liu","year":"2020","journal-title":"Nat. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jama.2016.2420","article-title":"Data Sharing: An Ethical and Scientific Imperative","volume":"315","author":"Bauchner","year":"2016","journal-title":"JAMA"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.sbspro.2011.12.091","article-title":"Benefits of Collaborative Learning","volume":"31","author":"Laal","year":"2012","journal-title":"Procedia-Soc. Behav. Sci."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Lacalamita, A., Serino, G., Pantaleo, E., Monaco, A., Amoroso, N., Bellantuono, L., Piccinno, E., Scalavino, V., Dituri, F., and Tangaro, S. (2023). Artificial Intelligence and Complex Network Approaches Reveal Potential Gene Biomarkers for Hepatocellular Carcinoma. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242015286"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Gutierrez-Chakraborty, E., Chakraborty, D., Das, D., and Bai, Y. (2023). Discovering Novel Prognostic Biomarkers of Hepatocellular Carcinoma Using eXplainable Artificial Intelligence. bioRxiv, bioRxiv:2023.11.27.568859.","DOI":"10.1101\/2023.11.27.568859"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Yagin, F.H., El Shawi, R., Algarni, A., Colak, C., Al-Hashem, F., and Ardig\u00f2, L.P. (2024). Metabolomics Biomarker Discovery to Optimize Hepatocellular Carcinoma Diagnosis: Methodology Integrating AutoML and Explainable Artificial Intelligence. Diagnostics, 14.","DOI":"10.3390\/diagnostics14182049"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"102144","DOI":"10.1016\/j.arr.2023.102144","article-title":"eXplainable Artificial Intelligence (XAI) in Aging Clock Models","volume":"93","author":"Kalyakulina","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"101896","DOI":"10.1016\/j.inffus.2023.101896","article-title":"Connecting the Dots in Trustworthy Artificial Intelligence: From AI Principles, Ethics, and Key Requirements to Responsible AI Systems and Regulation","volume":"99","author":"Coeckelbergh","year":"2023","journal-title":"Inf. Fusion"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Radclyffe, C., Ribeiro, M., and Wortham, R.H. (2023). The Assessment List for Trustworthy Artificial Intelligence: A Review and Recommendations. Front. Artif. Intell., 6.","DOI":"10.3389\/frai.2023.1020592"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/3\/252\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:33:55Z","timestamp":1759919635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/3\/252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":109,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["diagnostics15030252"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15030252","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]}}}